The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Validity of Glycated Hemoglobin in Screening and Diagnosing Type 2 Diabetes Mellitus in Chinese Subjects

  • Yu, Yun (Diabetes Care and Research Center, Jiangsu Province Institute of Geriatrics) ;
  • Ouyang, Xiao-Jun (Diabetes Care and Research Center, Jiangsu Province Institute of Geriatrics) ;
  • Lou, Qing-Lin (Diabetes Care and Research Center, Jiangsu Province Institute of Geriatrics) ;
  • Gu, Liu-Bao (Diabetes Care and Research Center, Jiangsu Province Institute of Geriatrics) ;
  • Mo, Yong-Zhen (Diabetes Care and Research Center, Jiangsu Province Institute of Geriatrics) ;
  • Ko, Gary T. (Department of Medicine and Therapeutics, Prince of Wales Hospital, the Chinese University of Hong Kong) ;
  • Chow, Chun-Chung (Department of Medicine and Therapeutics, Prince of Wales Hospital, the Chinese University of Hong Kong) ;
  • So, Wing-Yee (Department of Medicine and Therapeutics, Prince of Wales Hospital, the Chinese University of Hong Kong) ;
  • Ma, Ronald (Department of Medicine and Therapeutics, Prince of Wales Hospital, the Chinese University of Hong Kong) ;
  • Kong, Alice (Department of Medicine and Therapeutics, Prince of Wales Hospital, the Chinese University of Hong Kong) ;
  • Brown, Nicola (Asia Diabetes Foundation) ;
  • Nan, Jennifer (Asia Diabetes Foundation) ;
  • Chan, Juliana (Department of Medicine and Therapeutics, Prince of Wales Hospital, the Chinese University of Hong Kong) ;
  • Bian, Rong-Wen (Diabetes Care and Research Center, Jiangsu Province Institute of Geriatrics)
  • Published : 2012.03.01
⟨ Previous Next ⟩

Abstract

Background/Aims: The application of glycated hemoglobin ($HbA_{1c}$) for the diagnosis of diabetes is currently under extensive discussion. In this study, we explored the validity of using $HbA_{1c}$ as a screening and diagnostic test in Chinese subjects recruited in Nanjing, China. Methods: In total, 497 subjects (361 men and 136 women) with fasting plasma glucose (PG) ${\geq}\;5.6 mmol/L$ were recruited to undergo the oral glucose tolerance test (OGTT) and $HbA_{1c}$ test. Plasma lipid, uric acid, and blood pressure were also measured. Results: Using a receiver operating characteristic curve, the optimal cutoff point of $HbA_{1c}$ related to diabetes diagnosed by the OGTT was 6.3%, with a sensitivity and specificity of 79.6% and 82.2%, respectively, and the area under the curve was 0.87 (95% confidence interval, 0.83 to 0.92). A $HbA_{1c}$ level of 6.5% had a sensitivity and specificity of 62.7% and 93.5%, respectively. When comparing the $HbA_{1c}$ ${\geq}\;6.5%$ or OGTT methods for diagnosing diabetes, the former group had significantly higher $HbA_{1c}$ levels and lower levels of fasting and 2-hour PG than the latter group. No significant difference was observed in the other metabolism indexes between the two groups. Conclusions: Our results suggest that $HbA_{1c}$ ${\geq}\;6.5%$ has reasonably good specificity for diagnosing diabetes in Chinese subjects, which is in concordance with the American Diabetes Association recommendations.

Keywords

References

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34 Suppl 1:S62-S69. https://doi.org/10.2337/dc11-S062
  2. Ko GT, Chan JC, Woo J, et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 1998;35(Pt 1):62-67. https://doi.org/10.1177/000456329803500107
  3. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007;24:333-343. https://doi.org/10.1111/j.1464-5491.2007.02106.x
  4. Weykamp C, John WG, Mosca A. A review of the challenge in measuring hemoglobin A1c. J Diabetes Sci Technol 2009;3:439-445. https://doi.org/10.1177/193229680900300306
  5. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33 Suppl 1:S11-S61. https://doi.org/10.2337/dc10-S011
  6. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
  7. Gregg EW, Cadwell BL, Cheng YJ, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 2004;27:2806-2812. https://doi.org/10.2337/diacare.27.12.2806
  8. Ganda OP, Day JL, Soeldner JS, Connon JJ, Gleason RE. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 1978;27:715-725. https://doi.org/10.2337/diabetes.27.7.715
  9. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167:1545-1551. https://doi.org/10.1001/archinte.167.14.1545
  10. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334. https://doi.org/10.2337/dc09-9033
  11. Motta M, Bennati E, Cardillo E, Ferlito L, Malaguarnera M. The value of glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly. Arch Gerontol Geriatr 2010;50:60-64. https://doi.org/10.1016/j.archger.2009.01.012
  12. Herman WH, Fajans SS. Hemoglobin A1c for the diagnosis of diabetes: practical considerations. Pol Arch Med Wewn 2010;120:37-40.
  13. Miedema K. Towards worldwide standardisation of HbA1c determination. Diabetologia 2004;47:1143-1148. https://doi.org/10.1007/s00125-004-1453-0
  14. Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478. https://doi.org/10.2337/dc08-0545
  15. Herman WH, Ma Y, Uwaifo G, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453-2457. https://doi.org/10.2337/dc06-2003
  16. Viberti G, Lachin J, Holman R, et al. A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of type 2 diabetic patients in North America and Europe. Diabet Med 2006;23:1289-1294. https://doi.org/10.1111/j.1464-5491.2006.02022.x
  17. Manley SE, Sikaris KA, Lu ZX, et al. Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med 2009;26:115-121. https://doi.org/10.1111/j.1464-5491.2008.02652.x
  18. Hu Y, Liu W, Chen Y, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010;47:231-236. https://doi.org/10.1007/s00592-009-0143-2
  19. Mohan V, Vijayachandrika V, Gokulakrishnan K, et al. A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care 2010;33:515-519. https://doi.org/10.2337/dc09-1694
  20. Nakagami T, Tominaga M, Nishimura R, et al. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract 2007;76:251-256. https://doi.org/10.1016/j.diabres.2006.09.015
  21. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007;30:2233-2235. https://doi.org/10.2337/dc07-0585
  22. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-2453. https://doi.org/10.1210/jc.2007-2174
  23. Sabanayagam C, Liew G, Tai ES, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 2009;52:1279-1289. https://doi.org/10.1007/s00125-009-1360-5

Cited by

  1. Glycated haemoglobin A1c for diagnosing diabetes in Chinese subjects over 50？years old: a community‐based cross‐sectional study vol.80, pp.5, 2012, https://doi.org/10.1111/cen.12202
  2. Dietary pattern trajectories during 15 years of follow-up and HbA1c, insulin resistance and diabetes prevalence among Chinese adults vol.68, pp.8, 2014, https://doi.org/10.1136/jech-2013-203560
  3. Evaluation of Glycated Hemoglobin (HbA1c) for Diagnosing Type 2 Diabetes and Prediabetes among Palestinian Arab Population vol.9, pp.2, 2014, https://doi.org/10.1371/journal.pone.0088123
  4. Prevalence of undiagnosed diabetes and pre-diabetes among hypertensive patients attending Kiambu district Hospital, Kenya: a cross-sectional study vol.22, pp.None, 2012, https://doi.org/10.11604/pamj.2015.22.286.7395
  5. Derivation & validation of glycosylated haemoglobin (HbA 1c ) cut-off value as a diagnostic test for type 2 diabetes in south Indian population vol.144, pp.2, 2012, https://doi.org/10.4103/0971-5916.195035
  6. Using both principal component analysis and reduced rank regression to study dietary patterns and diabetes in Chinese adults vol.19, pp.2, 2016, https://doi.org/10.1017/s1368980014003103
  7. Comparing glucose and hemoglobin A1c diagnostic tests among a high metabolic risk Hispanic population vol.33, pp.4, 2017, https://doi.org/10.1002/dmrr.2874
  8. A pilot study: effect of erythrocyte lifespan determined by a modified carbon monoxide breath test on glycosylated hemoglobin interpretation vol.14, pp.2, 2012, https://doi.org/10.1088/1752-7163/ab75f8